{
    "nctId": "NCT03307044",
    "briefTitle": "Fractional CO2 Laser Therapy for Survivors of Breast Malignancies",
    "officialTitle": "Fractional CO2 Laser Therapy for Survivors of Breast Malignancies",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Carcinoma, Cancer Survivor, Cervical Carcinoma, Dyspareunia, Vaginal Dryness",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 66,
    "primaryOutcomeMeasure": "Change in Vaginal Assessment Scale score",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with non-metastatic breast cancer with any hormone receptor and Her 2 neu status who have completed surgery, chemotherapy, and radiation and are currently on endocrine therapy, single agent Herceptin, or observation\n* Symptoms of urogenital atrophy including dyspareunia or vaginal dryness\n\nExclusion Criteria:\n\n* Patients with metastatic breast cancer\n* Vaginal stenosis which would not allow vaginal probe to be placed (based on physician exam)\n* Active genital infection at the time of enrollment (if present initially, can be treated and then patient can be re-evaluated for eligibility)\n* Pelvic organ prolapse greater than stage II\n* Prior reconstructive pelvic surgery involving mesh\n* Hormone replacement therapy, vaginal estrogen therapy, DHEA, or biosynthetics within 6 weeks prior to enrollment",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}